Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gene Therapy
Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
November 9th, 2007
Sigma-Aldrich(TM) (NASDAQ:SIAL), a life science company dedicated to providing state-of-the-art chemical and biotechnology products to the world's researchers, and Oxford BioMedica , a leading gene therapy company, announced that they received a key order confirming the strength and validity of intellectual property owned by Oxford BioMedica and licensed exclusively in the research field to Sigma-Aldrich. The ruling was part of the construction of patent claim terms in the patent infringement suit brought against Open Biosystems, Inc. The lawsuit, which is pending in the U.S. District Court for the Eastern District of Missouri, alleges that Open Biosystems infringes U.S. Patent Nos....
Source: Biotech Law Weekly (2007-11-09)
|
|
Advertisement |
|
|
|
